Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Clinical trial NCT02322021 · TERMINATED

Trial details

NCT number: NCT02322021
Sponsor: Eisai Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Dementia, Alzheimer Type

Start date: 2014-11-26
Primary completion: 2019-12-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.